Publication Name	World Journal of Gastroenterology
Manuscript ID	33137
Country	Croatia

Received	2017-02-06 18:12
Peer-Review Started	2017-02-07 13:13
To Make the First Decision	2017-03-03 10:06
Return for Revision	2017-03-07 10:36
Revised	2017-04-13 02:20
Second Decision	2017-04-14 17:35
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2017-04-21 15:21
Articles in Press	2017-04-21 15:21
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-05-03 18:22
Publish the Manuscript Online	2017-05-15 06:16

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishin Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Inflammatory bowel disease in liver transplanted patients
Manuscript Source	Invited Manuscript
All Author List	Tajana Filipec Kanizaj and Maja Mijic
Funding Agency and Grant Number
Corresponding Author	Tajana Filipec Kanizaj, Assistant Professor, PhD, Department of Gastroenterology, University Hospital Merkur, School of Medicine, University of Zagreb, Zajceva 19, Zagreb 10000, Croatia. tajana.filipec@gmail.com
Key Words	Inflammatory bowel disease; Anti-TNF alpha therapy; Liver transplantation; Immunomodulatory therapy; Immunosuppression; Proctoproctocolectomy; Risk factors
Core Tip	Management of inflammatory bowel disease in setting of liver transplantation (LT) is a clinical challenge because of intermittent flares and remissions of the disease, regardless of post-LT immunosuppression to prevent organ rejection. In this article we report new insight on actual knowledge ondiagnostic and treatment opportunities in pre- and post-transplant period.
Publish Date	2017-05-15 06:16
Citation	Filipec Kanizaj T, Mijic M. Inflammatory bowel disease in liver transplanted patients. World J Gastroenterol 2017; 23(18): 3214-3227
URL	http://www.wjgnet.com/1007-9327/full/v23/i18/3214.htm
DOI	http://dx.doi.org/10.3748/wjg.v23.i18.3214

Full Article (PDF)	WJG-23-3214.pdf
Full Article (Word)	WJG-23-3214.doc
Manuscript File	33137-Review.docx
Answering Reviewers	33137-Answering reviewers.pdf
Audio Core Tip	33137-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	33137-Conflict-of-interest statement.pdf
Copyright License Agreement	33137-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	33137-Language certificate.pdf
Peer-review Report	33137-Peer-review(s).pdf
Scientific Misconduct Check	33137-Scientific misconduct check.pdf
Scientific Editor Work List	33137-Scientific editor work list.pdf